Target finder


Insert sequence accession number

Cancel

Record ID: NRN_CS182175

Description:Sequence 2 from Patent EP1588718. MEDICAMENT AND METHOD FOR AMELIORATIONG BRAIN FUNCTION. Lymphangiogenesis accelerator. Hepatocyte Growth Factor Gene Therapy to Enhance Musculocutaneous Flap Survival. Lymphangiogenesis accelerator. Sequence 2 from patent US 7790692.
Length:7681 bp
Found in databases: nrnl1
Found in the following 5 patents: EP1588718 (lens, espacenet) WO2007013603 (lens, espacenet) JP2005314404 (lens, espacenet) JP2008163007 (lens, espacenet) US7790692 (lens, espacenet)

2 amplicons

View all records targeted by these methods

View these methods in JRC GMO-Matrix



0 768 1536 2304 3072 3841 4609 5377 6145 6913 7681 QL-ELE-00-002 QL-ELE-00-003

Legend

Event-specific method
Element-specific method
Construct-specific method
Taxon-specific method

Record ID Database Record description Record length Taxon Method Amplicon size Match details
NRN_CS182175 nrnl1 Sequence 2 from Patent EP1588718. ... 7681 bp unidentified QL-ELE-00-002 215 bp View
NRN_CS182175 nrnl1 Sequence 2 from Patent EP1588718. ... 7681 bp unidentified QL-ELE-00-003 173 bp View


Related publications:

Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101. 

Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.